About this episode

The episode discusses Eli Lilly's acquisition of AtaiBeckley and other significant developments in the biotech sector.

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF.  Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu -Sam Fazeli, Bloomberg Intelligence, Director of Research: Healthcare, Defence, Industrials & Auto, discusses the latest in the biotech sector. Eli Lilly & Co. agreed to buy AtaiBeckley Inc. for as much as $3.8 billion, underscoring growing interest from large drugmakers in psychedelic medicine. Separately, Merck & Co. won US regulatory approval of a pill called Lipfendra to reduce LDL cholesterol. -Matt Henriksson, Bloomberg Intelligence Senior Equity Analyst, discusses earnings from Abbott Laboratories. Abbott Laboratories raised its 2026 profit guidance after a stronger-than-expected second quarter driven by improved performance across most of its business lines. The company now expects adjusted earnings to fall between $5.45 to $5.60 a share this year, and shares rose 14% after the announcement. -Mandeep Singh, Global Head of Tech Research for Bloomberg Intelligence, discusses Taiwan Semiconductor Manufacturing Co. raising its spending and revenue projections for the year, reflecting confidence that growth in demand for chips…

People in this episode

Hosts: Paul Sweeney, Scarlet Fu

Guests: Sam Fazeli, Matt Henriksson, Mandeep Singh

Topics covered

• biotech
• psychedelic medicine
• earnings report
• chip demand
• mergers and acquisitions

Keywords

• Eli Lilly
• AtaiBeckley
• psychedelic drugs
• Abbott Laboratories
• Taiwan Semiconductor
• Uber
• Delivery Hero
• Merck
• Lipfendra

Mentioned in this episode

Organizations: Eli Lilly & Co., AtaiBeckley Inc., Merck & Co., Abbott Laboratories, Taiwan Semiconductor Manufacturing Co., Uber Technologies Inc., Delivery Hero SE

Products: Lipfendra

More episodes of Bloomberg Intelligence

• GM Boosts 2026 Outlook on Premium Pricing for Big Trucks · July 21, 2026 · 18 min
• Moonshot Plans IPO in Six Months After China AI Breakthrough · July 20, 2026 · 21 min
• Bloomberg Money: The Opportunity Cost of Cautious Investing · July 18, 2026 · 40 min
• Chip Stocks Sink Into Bear Market Territory as AI Rally Fizzles · July 17, 2026 · 18 min
• Morgan Stanley Joins Wall Street Rivals’ Stock-Trading Boon · July 15, 2026 · 6 min
• US Bank Earnings Surpass Wall Street Expectations · July 14, 2026 · 4 min

Explore listener stats, chart rankings, contacts and more on the Bloomberg Intelligence podcast page.